000			01528 a2200409 4500
005			20250512002802.0
264		0	_c19890829
008			198908s 0 0 eng d
022			_a0896-8411
024	7		_a10.1016/0896-8411(89)90109-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aBeraud, E
245	0	0	_aVaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccination. _h[electronic resource]
260			_bJournal of autoimmunity _cFeb 1989
300			_a75-86 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAutoimmune Diseases _xprevention & control
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aCell Line
650	0	4	_aConvalescence
650	0	4	_aEncephalomyelitis, Autoimmune, Experimental _xetiology
650	0	4	_aImmunity, Innate
650	0	4	_aImmunization, Passive
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aInjections, Intravenous
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMyelin Basic Protein _ximmunology
650	0	4	_aRats
650	0	4	_aVaccination
700	1		_aLider, O
700	1		_aBaharav, E
700	1		_aReshef, T
700	1		_aCohen, I R
773	0		_tJournal of autoimmunity _gvol. 2 _gno. 1 _gp. 75-86
856	4	0	_uhttps://doi.org/10.1016/0896-8411(89)90109-1 _zAvailable from publisher's website
999			_c2479768 _d2479768